Zacks analyst blog highlights Assertio Holdings, Brookfield Infrastructure, UnitedHealth and General Mills.

0

For immediate release

Chicago, IL – July 6, 2022 – Zacks.com announces the list of stocks featured in the analyst blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and financial markets. Stocks recently featured in the blog include: Assertio Holdings, Inc. ASRT, Brookfield Infrastructure Partners LP BIP, UnitedHealth Group Incorporated UNH and General Mills, Inc. GIS.

Here are the highlights from Tuesday’s analyst blog:

Beat the market like Zacks with these targeted actions

Last week, the three most followed indexes posted their fourth losing week in five. The S&P 500 fell 2.2%, while the Dow Jones Industrial Average and the tech-heavy Nasdaq lost 1.3% and 4.1%, respectively.

Recession fears took center stage as economic data released over the week showed falling consumer spending and disposable income. Concerns about further monetary policy tightening clouded markets.

The real bottom of this market cycle could still be ahead. While the economy has not yet entered a recession, the odds of Wall Street returning to a bull market soon are quite low.

Regardless of market conditions, we at Zacks provide investors with unbiased advice on how to beat the market.

Zacks Research guided investors last week with its proven methodologies, as usual. Given the uncertainty in the market, you might want to check out our exploits to better prepare for your next move.

Here are some of our key achievements from the past week:

Assertio Holdings, Inc. Stock Jumps on Zacks Ranking Upgrade

Shares of Assertio Holdings, Inc. gained 15.4% since being upgraded to Zacks #1 (Strong Buy) on June 25. The rating upgrade was driven primarily by an upward trend in earnings estimates, one of the most powerful forces impacting stock prices. The evolution of a company’s earnings is at the heart of the Zacks rating.

For ASRT, the current year EPS consensus estimate of $0.40 has been revised up 14.3% in the past two months.

Rising earnings estimates and the consequent upgrade of Zacks Rank for ASRT imply an improvement in the underlying business of the company. And investors began to show their appreciation for this improving trading trend by pushing the stock higher.

The Zacks Rank stock rating system, which uses four factors tied to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive track record. externally audited record, with Zacks Rank #1 stocks generating an average annual return of +24.8% since 1988. You can see the full list of today’s Zacks Rank #1 (Strong Buy) stocks here >> >

View Assertio’s EPS History and Sales Here>>>

Zacks Focus List Brookfield Infra Surges Stock Model Portfolio

stock shares Brookfield Infrastructure Partners LP, which is on the Zacks Focus List, is up nearly 5% over the past week. The Zacks Focus List is a model portfolio of 50 handpicked stocks that have the right fundamental ingredients to outperform the market over the next 12 months. These 50 stocks are selected from a long list of stocks with the highest Zacks rank.

Brookfield was added to the Focus list on August 16, 2019, at $26.46 per share. The stock has gained 47.1% since then to close the last trading session at $38.93.

Since its inception on February 1, 1996, the Focus List portfolio has generated an annualized return of +12.9%.

Unlock all of our powerful research, tools and analytics, including Focus List, Zacks #1 Rank List, Stock Research Reports, ESP Zacks Earnings Filter, Premium Filter and more, as part of Zacks Premium. Get full access now >>

Zacks ECAP Stock UnitedHealth Offers Solid Returns

UnitedHealth Group Incorporated, a component of our Earnings Certain Admiral (ECAP) portfolio, jumped 4.4% last week. ECAP is a model portfolio of 30 concentrated, ultra-defensive and long-term Buy and Hold stocks.

With little or no turnover and an annual rebalancing frequency, ECAP seeks to minimize capital losses by holding shares of companies whose earnings streams have a proven track record of more than 20 years of surviving periods. recession with minimal impact on overall earnings growth relative to the broader S&P 500. .

In terms of last week’s returns, Church & Dwight Co., Inc. (CHD) and The Clorox Company (CLX) followed UnitedHealth with gains of 2.9% and 2.2%, respectively.

ECAP and many other model portfolios are available as part of Zacks Advisor Tools, a cloud-based solution for accessing Zacks’ award-winning stock, mutual fund, and ETF research. Click here to schedule a demo.

Zacks ECDP Stock General Mills Sees Significant Growth

General Mills, Inc., part of our Earnings Certain Dividend (ECDP) portfolio, jumped 7.3% last week. Investors’ inclination towards quality dividend-paying stocks to secure an income stream in an environment of heightened market volatility supported this performance. View General Mill’s Dividend History Here>>>

With an extremely low beta and a history of minimal earnings variability over the past 20+ years, this 25-stock portfolio helps to significantly mitigate risk. ECDP has consistently outperformed the S&P 500 Dividend Aristocrats ETF (NOBL).

Click here to access this portfolio on Zacks Advisor Tools.

Why haven’t you watched Zacks best action?

Our top 5 performing strategies swept away the S&P’s impressive +28.8% gain in 2021. Surprisingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today, you can access their live selections at no cost or obligation.

See Free Stocks >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]

https://www.zacks.com

Past performance is not indicative of future results. The potential for loss is inherent in any investment. This document is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether any investment is suitable for any particular investor. It should not be assumed that investments in the securities, companies, sectors or markets identified and described have been or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management of securities. These returns come from hypothetical portfolios composed of stocks with Zacks Rank = 1 that have been rebalanced monthly without transaction fees. These are not the returns of actual stock portfolios. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for more information on the performance figures displayed in this press release.

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could step in at any time.

This company could rival or surpass other recent Zacks stocks which are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.

Free: See our best stock and our 4 finalists >>

Click to get this free report

UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report

Brookfield Infrastructure Partners LP (BIP): Free Stock Analysis Report

General Mills, Inc. (GIS): Free Inventory Analysis Report

Assertio Holdings, Inc. (ASRT): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Share.

Comments are closed.